Nina Sanford shared a post on X:
“Great slide by Josh Smith of major non-op rectal RCTs.
In total >2,200 patients in trials with cCR as primary endpoint!
These trials will better inform patient selection and treatment technique to optimize non-op management.”
Nina Niu Sanford is an Assistant Professor and Chief of Gastrointestinal Radiation Oncology at Harvard/Brigham and Women’s Hospital/Massachusetts General Hospital. She specializes in treating gastrointestinal cancers and actively participates in clinical trials combining high-dose radiation therapy with immunotherapy. Additionally, she researches healthcare access disparities and conducts pan-cancer outcomes research using large databases.